You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

Actavis Elizabeth Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and seventeen approved drugs.

There are five tentative approvals on ACTAVIS ELIZABETH drugs.

Drugs and US Patents for Actavis Elizabeth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 074260-003 Sep 3, 1993 AB RX No Yes ⤷  Sign Up ⤷  Sign Up
Actavis Elizabeth MORPHINE SULFATE morphine sulfate TABLET, EXTENDED RELEASE;ORAL 203849-001 Apr 6, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up
Actavis Elizabeth GLYBURIDE glyburide TABLET;ORAL 075947-002 Nov 14, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.